menopause

Astellas scores a pair of trial wins for menopausal hot flash med, raising the pitch of looming Bayer standoff
Astellas scores a pair of trial wins for menopausal hot flash med, raising the pitch of looming Bayer standoff
Endpoints
Astellas
clinical trials
fezolinetant
menopause
hot flashes
Flag link:
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Fierce Biotech
Bayer
KaNDy Therapeutics
M&A
Women's Health
menopause
hot flashes
NT-814
Flag link:
Astellas pushes non-hormonal menopause drug into phase 3
Astellas pushes non-hormonal menopause drug into phase 3
Pharmaforum
Astellas
menopause
clinical trials
fezolinetant
Flag link:
Concept Device Designed to Tame Menopausal Hot Flashes
Concept Device Designed to Tame Menopausal Hot Flashes
Medical Devices and Diagnostics Industry
devices
Cambridge Consultants
hot flashes
menopause
Flag link:
FDA approves TherapeuticsMD's menopause drug
FDA approves TherapeuticsMD's menopause drug
Yahoo/Reuters
TherapeuticsMD
menopause
Bijuva
Flag link:
Women’s health firm KaNDy raises $32M for menopause study
Women’s health firm KaNDy raises $32M for menopause study
Fierce Biotech
KaNDy Therapeutics
clinical trials
menopause
NT-814
Flag link:
FDA approves TherapeuticsMD's hormone therapy
FDA approves TherapeuticsMD's hormone therapy
Yahoo/Reuters
FDA
TherapeuticsMD
menopause
Imvexxy
vaginal atrophy
Flag link:
Shire's Vyvanse could bag another lucrative new market in menopausal women
Shire's Vyvanse could bag another lucrative new market in menopausal women
Fierce Pharma Marketing
Shire
menopause
Vyvanse
Flag link:
Mylan Launches First Generic Version of Menopause Treatment
Mylan Launches First Generic Version of Menopause Treatment
Drug Discovery and Development
Mylan Labs
generics
menopause
Novartis
Vivelle-Dot
Flag link:
Ligand Wins EU Approval For Duavive
Ligand Wins EU Approval For Duavive
Seeking Alpha
Duavive
Ligand
menopause
Flag link:
Pfizer: The Menopause Opportunity
Pfizer: The Menopause Opportunity
Seeking Alpha
Pfizer
Duavee
menopause
Flag link:
Pfizer: The Menopause Opportunity
Pfizer: The Menopause Opportunity
Seeking Alpha
Pfizer
Duavee
menopause
Ligand Pharmaceuticals
Eli Lilly
Hisamitsu
hot flashes
Flag link:
Did Pfizer and Ligand Just Get a New Winning Drug Approved?
Did Pfizer and Ligand Just Get a New Winning Drug Approved?
Wall St. Cheat Sheet
Pfizer
Ligand
Duavee
hot flashes
menopause
osteoporosis
Flag link:
FDA Approves New Hot Flash Treatment for Menopause
FDA Approves New Hot Flash Treatment for Menopause
Investor Place
Duavee
menopause
Pfizer
Ligand Pharmaceuticals
Flag link:
Pfizer, Ligand Win U.S. Approval for Hot Flash Therapy
Pfizer, Ligand Win U.S. Approval for Hot Flash Therapy
Bloomberg
Pfizer
Ligand
hot flashes
menopause
osteoporosis
FDA
Duavee
Flag link:
Pfizer’s Premarin for Menopause Linked to Blood Clot Risk
Pfizer’s Premarin for Menopause Linked to Blood Clot Risk
Bloomberg
Premarin
Pfizer
menopause
Flag link:
Safety Concerns May Prevent FDA Approval Of Ligand's Drug Aprela
Safety Concerns May Prevent FDA Approval Of Ligand's Drug Aprela
Seeking Alpha
FDA
Ligand
Aprela
menopause
post-menopausal osteoporosis
Flag link:
FDA approves first non-hormonal treatment for menopausal hot flashes
FDA approves first non-hormonal treatment for menopausal hot flashes
Reuters
FDA
menopause
Flag link:
Hormone Drugs Don’t Harm Brain for Some Menopausal Women
Hormone Drugs Don’t Harm Brain for Some Menopausal Women
Bloomberg
menopause
HRT
Flag link:
FDA Issues Complete Response Letter on Sefelsa New Drug Application
FDA Issues Complete Response Letter on Sefelsa New Drug Application
Sacramento Bee, CA
gabapentin
menopause
Sefelsa
Depomed
Flag link:

Pages